针对CD70的CAR-T/NK疗法:理由,进展和未来的方向
Sijia Yan1, Xiaojian Zhu1, Yi Xiao1
1Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.
Translational oncology
|October 3, 2025
概括
针对CD70的化学抗原受体T和自然杀手 (CAR-T/NK) 细胞显示出治疗各种血液癌症和固体瘤的前景. 目前正在进行的研究和临床试验为CD70阳性恶性瘤患者提供了新的希望.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 细胞疗法细胞疗法
背景情况:
- 化学抗原受体T和自然杀手 (CAR-T/NK) 细胞代表了细胞免疫疗法的重大进步,证明了在治疗血液病方面的成功.
- CD70是一种在各种血液性恶性瘤和固体瘤的瘤细胞上发现的表面抗原,使其成为一个有前途的治疗标.
研究的目的:
- 探索CAR-T/NK细胞的潜力,这些细胞被设计为针对CD70抗原进行癌症治疗.
- 审查目前临床前研究和临床试验的现状,调查针对CD70的CAR-T/NK细胞疗法.
主要方法:
- 审查现有的科学文献和临床试验数据.
- 在各种癌症类型中分析CD70表达模式.
- 在临床前模型和早期试验中评估针对CD70的CAR-T/NK细胞疗法的疗效和安全性.
主要成果:
- 在急性髓性白血病,非霍奇金淋巴瘤,多发性骨髓瘤,细胞癌,骨肉瘤和质瘤中,CD70在瘤细胞上表达.
- 一些针对CD70的CAR-T/NK细胞疗法正在开发中,具有有希望的临床前数据和正在进行的临床研究.
结论:
- 用CAR-T/NK细胞向CD70为一系列CD70阳性血液和固体瘤提供了一种新的和有希望的治疗策略.
- 需要进一步进行临床评估,以确定这些先进免疫疗法的安全性和有效性.
相关概念视频
01:27Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
02:57Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
01:27Cytotoxic T Cells-mediated Immune Response
6.5K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
6.5K